Migdal Insurance & Financial Holdings Ltd. Repligen Corp Transaction History

Migdal Insurance & Financial Holdings Ltd.

$6.18 Billion
Q3 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2022 May 02, 2022	SELL	$161.19 - $257.96 $2,256 - $3,611	-14 Closed	0 $0
Q1 2021 May 04, 2021	BUY	$180.37 - $226.26 $2,525 - $3,167	14 New	14 $3,000

Others Institutions Holding RGEN

# of Institutions

488

Shares Held

54.2M

Call Options Held

341K

Put Options Held

235K

Black Rock Inc. New York, NY

7.57M
Shares

$1.11 Billion
0.02% of portfolio
Price T Rowe Associates Inc Baltimore, MD

6.39M
Shares

$939 Million
0.11% of portfolio
Vanguard Group Inc Valley Forge, PA

5.04M
Shares

$741 Million
0.01% of portfolio
State Street Corp Boston, MA

1.62M
Shares

$239 Million
0.01% of portfolio
Champlain Investment Partners, LLC Burlington, VT

1.42M
Shares

$209 Million
1.34% of portfolio

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.15B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Migdal Insurance & Financial Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Migdal Insurance & Financial Holdings Ltd. with notifications on news.

Account